Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Biopreservation Market Analysis

ID: MRFR/HC/4946-HCR
200 Pages
Rahul Gotadki
March 2026

Biopreservation Market Research Report By Application (Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, Regenerative Medicine), By Product Type (Biopreservation Media, Freezers, Cryogenic Storage Systems, Accessories), By End User (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, Clinics), By Storage Type (Cryopreservation, Controlled Rate Freezing, Ultra-Low Temperature Storage) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Biopreservation Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Market Analysis

In-depth Analysis of Biopreservation Market Industry Landscape

The biopreservation industry is changing due to cell therapy, regenerative medicine, and biobanking advances. To preserve biological material, cells, tissues, and organs for future use, biopreservation is done under regulated circumstances. Cell-based treatments and their growing use in drug development, personalized medicine, and the preservation of rare and precious biological specimens drive market dynamics.

Rising demand for cell treatments and regenerative medicine drives the biopreservation industry. Biopreservation solutions are needed due to the rise in clinical trials and research on emerging therapeutic techniques such stem cell and gene treatments. These sophisticated medicines depend on cell viability and functioning during storage, boosting the need for biopreservation methods.

Biobanking advances and precision medicine are driving the biopreservation industry. Biobanks preserve biological samples for research, diagnosis, and therapy. The necessity to retain various biological resources and the growing awareness of customized treatment drive biobanking institutions to adopt improved biopreservation technologies and processes.

Innovative biopreservation technologies and solutions drive industry change. Cryopreservation, vitrification, and other methods improve biopreservation efficiency and dependability. These developments address biological material preservation concerns and offer long-term storage options for complex structures like organs and tissues.

Key companies in the biopreservation market provide a variety of goods and services. Collaboration with research institutes, pharmaceutical firms, and healthcare providers is a typical way to extend market reach and meet different application demands. Novel formulations, storage methods, and biopreservation solution scalability are the subject of ongoing research.

Geographical differences in healthcare facilities and research capacities affect biopreservation market dynamics. Developed regions with advanced biotechnology and healthcare facilities employ biopreservation methods more. However, emerging economies are realizing the relevance of biobanking and biopreservation in scientific research and healthcare, expanding the market.

Market challenges include ethical and regulatory issues related to biological sample storage and usage. Market players must follow worldwide standards, ethics, and changing rules. Scalability and cost-effectiveness of biopreservation systems must to be addressed for wider implementation.

Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Biopreservation Market as of 2024?

<p>The Biopreservation Market was valued at 7.44 USD Billion in 2024.</p>

What is the projected market size for the Biopreservation Market in 2035?

<p>The market is projected to reach 12.4 USD Billion by 2035.</p>

What is the expected CAGR for the Biopreservation Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Biopreservation Market during 2025 - 2035 is 4.75%.</p>

Which application segment is anticipated to grow the most in the Biopreservation Market?

<p>The Clinical Applications segment is expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.</p>

What are the key product types in the Biopreservation Market?

<p>Key product types include Biopreservation Media, Freezers, Cryogenic Storage Systems, and Accessories.</p>

How much is the Biopreservation Media segment projected to be worth by 2035?

<p>The Biopreservation Media segment is projected to reach 4.0 USD Billion by 2035.</p>

Which end-user segment is likely to see significant growth in the Biopreservation Market?

<p>Pharmaceutical Companies are expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.</p>

What storage type is projected to have the highest valuation in the Biopreservation Market by 2035?

<p>Ultra-Low Temperature Storage is projected to reach 5.07 USD Billion by 2035.</p>

Who are the leading companies in the Biopreservation Market?

<p>Key players include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, and Danaher Corporation.</p>

What is the growth outlook for the Cryopreservation segment in the Biopreservation Market?

<p>The Cryopreservation segment is expected to grow from 2.5 USD Billion in 2024 to 4.1 USD Billion by 2035.</p>

Market Summary

As per Market Research Future analysis, the Biopreservation Market Size was estimated at 7.44 USD Billion in 2024. The Biopreservation industry is projected to grow from 7.793 USD Billion in 2025 to 12.4 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.75% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Biopreservation Market is poised for substantial growth driven by technological advancements and increasing demand for biopharmaceuticals.

  • Technological advancements in preservation techniques are reshaping the biopreservation landscape. North America remains the largest market, while Asia-Pacific is recognized as the fastest-growing region. The cell and tissue culture segment dominates the market, whereas regenerative medicine is emerging as the fastest-growing segment. Increasing adoption of biopreservation techniques and regulatory support are key drivers fueling market expansion.

Market Size & Forecast

2024 Market Size 7.44 (USD Billion)
2035 Market Size 12.4 (USD Billion)
CAGR (2025 - 2035) 4.75%
Largest Regional Market Share in 2024 North America

Major Players

Thermo Fisher Scientific (US), Merck KGaA (DE), Sartorius AG (DE), Danaher Corporation (US), BioLife Solutions (US), Lonza Group (CH), Fujifilm Holdings Corporation (JP), Becton, Dickinson and Company (US), Charles River Laboratories (US)

Market Trends

The biopreservation market is currently experiencing a notable transformation, driven by advancements in preservation techniques and an increasing demand for biopharmaceuticals, reflecting strong biopreservation market trends. This sector focuses on utilizing natural agents, such as microorganisms and enzymes, to extend the shelf life of biological materials. As the global population continues to grow, the need for effective preservation methods becomes more pressing, particularly in the food and healthcare industries including the food biopreservation market. The integration of biopreservation strategies not only enhances product longevity but also ensures safety and quality, which are paramount in today's market. Furthermore, the rise of personalized medicine and regenerative therapies is likely to propel the demand for solutions across the biopreservation systems market and biopreservation media market, as these fields require meticulous handling of biological samples.

In addition, the biopreservation market is witnessing a shift towards sustainable practices. Companies are increasingly adopting eco-friendly methods to meet regulatory standards and consumer preferences. This shift reflects evolving biopreservation market industry trends across the healthcare and life sciences sectors. As stakeholders in the biopreservation market continue to innovate, the focus on sustainability may lead to the development of novel preservation techniques that are both effective and environmentally responsible. Overall, the global biopreservation market appears poised for growth, driven by technological advancements and sustainability initiatives according to current biopreservation market analysis.

Technological Advancements in Preservation Techniques

The Biopreservation Market is witnessing rapid technological innovations that enhance preservation methods. These advancements include the development of novel cryopreservation techniques and improved storage solutions, which are crucial for maintaining the integrity of biological materials. As research progresses, these technologies may lead to more efficient and effective preservation strategies.

Growing Demand for Biopharmaceuticals

The increasing focus on biopharmaceuticals is significantly influencing the biopreservation market. As the healthcare sector expands, the need for reliable preservation methods becomes essential, further strengthening the biopreservation market share of advanced preservation technologies.

Shift Towards Sustainable Practices

There is a noticeable trend towards sustainability within the Biopreservation Market. Companies are increasingly adopting eco-friendly practices to align with consumer preferences and regulatory requirements. This shift not only addresses environmental concerns but also fosters innovation in preservation techniques that prioritize sustainability.

Biopreservation Market Market Drivers

Growing Awareness of Food Safety

The Biopreservation Market is increasingly shaped by the growing awareness of food safety among consumers and manufacturers alike. As foodborne illnesses remain a significant concern, there is a heightened focus on ensuring the safety and quality of food products. Biopreservation Market techniques, which utilize natural antimicrobial agents, are gaining traction as effective solutions to extend shelf life while maintaining product integrity. Market data suggests that the demand for biopreservation in the food sector is expected to rise, driven by consumer preferences for clean label products. This trend is likely to encourage food manufacturers to adopt biopreservation methods, thereby expanding the market. The emphasis on food safety is expected to foster innovation in biopreservation technologies, leading to the development of new solutions that address consumer concerns.

Regulatory Support for Biopreservation

The Biopreservation Market is benefiting from increasing regulatory support aimed at promoting safer and more effective preservation methods. Regulatory bodies are recognizing the importance of biopreservation in ensuring food safety and pharmaceutical efficacy. This support is reflected in the establishment of guidelines that encourage the use of biopreservation techniques, which are often viewed as more sustainable compared to traditional methods. For instance, regulations that favor natural preservatives over synthetic alternatives are likely to enhance market growth. Furthermore, as governments focus on public health and safety, the biopreservation market is expected to receive additional backing, potentially leading to a more favorable environment for innovation and investment in biopreservation technologies.

Rising Demand for Personalized Medicine

The Biopreservation Market is experiencing a surge in demand for personalized medicine, which is significantly influencing the biopreservation landscape. As healthcare shifts towards tailored treatments, the need for effective preservation of biological samples, such as tissues and cells, becomes paramount. This trend is supported by the increasing number of biobanks and research institutions focusing on personalized therapies. The biopreservation market is projected to expand as these institutions require reliable methods to store and preserve biological materials. The growth of personalized medicine is expected to drive innovations in biopreservation techniques, ensuring that samples remain viable for research and therapeutic applications. This evolving demand may lead to a more robust market, with companies developing specialized solutions to meet the unique needs of personalized medicine.

Technological Innovations in Biopreservation

The Biopreservation Market is significantly influenced by ongoing technological innovations that enhance preservation methods. Advances in cryopreservation, for instance, are enabling more effective storage of biological materials, which is crucial for both research and clinical applications. Technologies such as automated storage systems and improved cryoprotectants are being developed to optimize the preservation process. These innovations not only improve the viability of preserved samples but also reduce costs associated with storage and handling. As technology continues to evolve, the biopreservation market is likely to see an influx of new products and services that cater to the growing needs of various sectors, including healthcare and food industries. This technological momentum may lead to increased efficiency and effectiveness in biopreservation practices.

Increasing Adoption of Biopreservation Techniques

The Biopreservation Market is witnessing a notable increase in the adoption of biopreservation techniques across various sectors, particularly in pharmaceuticals and food preservation. This trend is driven by the need for enhanced shelf life and safety of products. According to recent data, the biopreservation market is projected to grow at a compound annual growth rate of approximately 12% over the next few years. This growth is attributed to the rising awareness of the benefits of biopreservation, including reduced reliance on chemical preservatives and improved product quality. As consumers become more health-conscious, the demand for natural preservation methods is likely to rise, further propelling the biopreservation market. Companies are increasingly investing in research and development to innovate and improve biopreservation methods, which may lead to more effective solutions in the industry.

Market Segment Insights

By Application: Cell and Tissue Culture (Largest) vs. Regenerative Medicine (Fastest-Growing)

The Biopreservation Market is diverse, with significant contributions from various applications. Among these, Cell and Tissue Culture holds the largest market share, driven by its essential role in research and development in biopharmaceuticals. Clinical Applications also contribute notably, focusing on FDA-approved therapies, while Gene and Drug Therapy vies for market space, primarily fueled by advancements in personalized medicine. In the realm of growth trends, <a href="https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220" target="_blank" title="regenerative medicine">Regenerative Medicine</a> is recognized as the fastest-growing segment, with rising investments and advancements in technologies enhancing cellular therapies. This growth is propelled by an increase in the incidence of chronic diseases, the aging population, and an emphasis on innovation in tissue engineering, which is shaping the future of healthcare applications across various sectors.

Cell and Tissue Culture: Dominant vs. Gene and Drug Therapy: Emerging

Cell and Tissue Culture serves as the dominant application in the Biopreservation Market, primarily due to its established role in supporting research in cellular therapies and vaccine production. This application is foundational for growing cell lines, which are critical for therapeutic development. In contrast, Gene and Drug Therapy is emerging as a significant player, leveraging innovations in genetic engineering and biotechnology. This segment is underpinned by the need for personalized treatments and the ongoing drive for novel drug development. Together, these applications illustrate the dynamic landscape of the market, where established practices coexist with transformative advancements aimed at addressing unmet medical needs.

By Product Type: Biopreservation Media (Largest) vs. Freezers (Fastest-Growing)

In the Biopreservation Market, the distribution of market share among product types reveals that Biopreservation Media holds the largest share, significantly contributing to the overall growth of this sector. Freezers, while not as dominant, are witnessing an impressive surge, driven by the increasing demand for reliable storage solutions in research, clinical applications, and biobanking. The competitive landscape is characterized by a focus on innovative technologies and improved storage capabilities that enhance the viability of biological samples. The growth trends in this segment are primarily fueled by advancements in biopreservation technologies and the rising emphasis on regenerative medicine and personalized therapies. Organizations are investing in robust biopreservation solutions to ensure the integrity and longevity of biological materials during storage and transport. Moreover, the emergence of new applications in biotechnology and pharmaceuticals is expected to drive the demand for both Freezers and Biopreservation Media, indicating a shift towards more comprehensive and efficient storage solutions.

Biopreservation Media (Dominant) vs. Cryogenic Storage Systems (Emerging)

Biopreservation Media is currently positioned as the dominant force in the Biopreservation Market, with its widespread use in various applications ranging from cellular therapies to drug development. It provides essential nutrients and growth factors that preserve the viability of biological samples, ensuring their efficacy during storage. In contrast, Cryogenic Storage Systems are emerging as a vital segment, gaining traction due to their ability to maintain biological materials at ultra-low temperatures. This technology is becoming increasingly important for applications requiring long-term storage and preservation of sensitive biological samples such as stem cells and reproductive cells. The synergy between these two product types is critical as they collectively enhance the functionality of biopreservation solutions and cater to the evolving needs of the biopharmaceutical and research communities.

By End User: Biotechnology Companies (Largest) vs. Pharmaceutical Companies (Fastest-Growing)

The biopreservation market shows a diverse distribution among its key end users, which include biotechnology companies, pharmaceutical companies, research institutions, hospitals, and clinics. Biotechnology companies currently hold the largest share in this market, driven by their reliance on biopreservation techniques to ensure the viability of biological materials. Pharmaceutical companies, while smaller in market share, are rapidly increasing their adoption of biopreservation solutions as they seek to enhance drug development processes and preserve sensitive biological components.

Biotechnology Companies (Dominant) vs. Pharmaceutical Companies (Emerging)

Biotechnology companies are viewed as the dominant players in the biopreservation market, leveraging advanced technologies to ensure the integrity and stability of biomaterials. These companies often engage in extensive research and development activities, resulting in a robust demand for biopreservation solutions that maintain the quality of biological samples. In contrast, pharmaceutical companies are emerging as significant users of biopreservation technologies. They are expanding their investments in this area to enhance drug discovery and development workflows. This trend is indicative of the growing importance of biopreservation in safeguarding the efficacy of therapeutics, as these companies recognize the need for reliable preservation methods to support their operations.

By Storage Type: Cryopreservation (Largest) vs. Ultra-Low Temperature Storage (Fastest-Growing)

In the Biopreservation Market, the storage type segment is characterized by distinct applications, with cryopreservation holding the largest market share due to its critical role in preserving biological materials such as stem cells and reproductive cells. Controlled Rate Freezing follows, offering a reliable method for preserving cells while minimizing ice crystal formation. Ultra-Low Temperature Storage is also significant, increasingly gaining traction as more organizations adopt advanced cooling technologies for long-term storage of sensitive biological samples.

Cryopreservation (Dominant) vs. Ultra-Low Temperature Storage (Emerging)

Cryopreservation is the dominant storage method in the biopreservation market, well-regarded for its effectiveness in preserving a wide range of biological samples at very low temperatures. This technique minimizes cellular damage and is crucial for applications in regenerative medicine and fertility treatments. Conversely, Ultra-Low Temperature Storage is emerging as a vital alternative, driven by the growing demand for safe and effective long-term storage solutions. The advancement of cooling technologies allows for better preservation of sensitive materials, such as pharmaceuticals and biologics, making it an appealing option for research and clinical applications. As both segments evolve, they reflect the broader trends towards efficiency and reliability in biopreservation.

Get more detailed insights about Biopreservation Market Research Report-Forecast to 2035

Regional Insights

The Biopreservation Market showed significant regional variations, with North America holding the largest share valued at 3.0 USD Billion in 2024 and projected to grow to 5.0 USD Billion by 2035, primarily driven by technological advancements and a well-established healthcare infrastructure.

Europe followed with a valuation of 2.0 USD Billion in 2024, expected to reach 3.5 USD Billion in 2035, reflecting a robust demand for biopreservation solutions amidst stringent regulatory standards. The APAC region, valued at 1.5 USD Billion in 2024 and 2.5 USD Billion in 2035, expanded rapidly due to increasing investments in healthcare and rising awareness of biopreservation techniques.

South America, with an initial valuation of 0.6 USD Billion in 2024, is projected to grow to 1.0 USD Billion by 2035, driven by improvements in health infrastructure and research initiatives. The Middle East and Africa (MEA) market, though smaller at 0.34 USD Billion in 2024, anticipates growth to 0.4 USD Billion by 2035, backed by government support for healthcare innovations. These figures underlined the diverse opportunities within the Biopreservation Market, where regional demands shape market growth and development.

Key Players and Competitive Insights

The Biopreservation Market is characterized by a rapidly evolving landscape, marked by increasing demand for biopreserved materials across various sectors, particularly in pharmaceuticals, biotechnology, and healthcare. As organizations strive to ensure the longevity and stability of biological samples, the competition among leading players intensifies. Technological advancements in cryopreservation, liquid nitrogen storage, and bio-banking solutions are pivotal in shaping the market dynamics. Companies are continuously innovating their product offerings, expanding their service capabilities, and establishing strategic partnerships to enhance their position in the market. The interplay between regional developments and global trends plays a significant role in influencing competitive strategies, with manufacturers focusing heavily on research and development to address the challenges of maintaining sample integrity. Panasonic Healthcare stands as a significant competitor in the Biopreservation Market, leveraging its expertise in advanced cold storage solutions. The company’s offerings include a range of refrigerators and freezers specifically designed for biopreservation applications, playing a critical role in preserving biological materials. With a strong emphasis on cutting-edge technology, Panasonic Healthcare ensures the reliability and efficiency of its products, ultimately supporting the healthcare and pharmaceutical industries in maintaining the quality of their samples. Their global presence, strengthened by extensive distribution networks and partnerships, allows Panasonic Healthcare to cater to a diverse clientele, from research institutions to large-scale pharmaceutical companies. The company’s commitment to innovation, coupled with its robust customer support framework, reinforces its competitive edge in this dynamic market. Fujifilm Irvine Scientific plays a crucial role in the Biopreservation Market by providing tailored solutions for cell culture and biopreservation needs. The company specializes in advanced cell therapies and media formulations that are essential for biopreservation and regenerative medicine. With a strong focus on innovation, Fujifilm Irvine Scientific continues to develop key products that enhance the quality and efficacy of biopreserved cells and tissues. Their strategic mergers and acquisitions have bolstered their position, allowing for the integration of new technologies and expanding their product portfolio. As a result, Fujifilm Irvine Scientific has established a solid market presence, catering to both research and clinical applications globally. The company’s strengths lie in its ability to deliver high-quality products while maintaining compliance with international regulatory standards, making it a trusted partner in the biopreservation sector.

Key Companies in the Biopreservation Market include

Industry Developments

  • Q2 2024: BioLife Solutions Announces Opening of New Biopreservation Market Media Manufacturing Facility in Bothell, Washington BioLife Solutions opened a new state-of-the-art manufacturing facility in Bothell, Washington, to expand production capacity for its biopreservation media products, supporting increased demand from cell and gene therapy customers.
  • Q2 2024: Thermo Fisher Scientific Launches New CryoStor® CS10 Biopreservation Market Solution for Cell Therapy Applications Thermo Fisher Scientific introduced CryoStor® CS10, a new biopreservation solution designed to enhance post-thaw cell viability for cell therapy developers and manufacturers.
  • Q1 2024: Panasonic Healthcare Unveils Next-Generation Ultra-Low Temperature Freezer for Biopreservation Market Panasonic Healthcare launched a new ultra-low temperature freezer model aimed at improving the reliability and energy efficiency of biopreservation for research and clinical applications.
  • Q2 2024: BioCision Announces Strategic Partnership with Cryoport to Advance Biopreservation Market Logistics BioCision entered into a strategic partnership with Cryoport to integrate BioCision’s biopreservation technologies with Cryoport’s logistics solutions, aiming to improve the transport and storage of temperature-sensitive biological materials.
  • Q1 2024: VWR International Expands Biopreservation Market Product Portfolio with Launch of New Storage Media VWR International launched a new line of biopreservation storage media, targeting biobanking and regenerative medicine customers seeking improved sample viability.
  • Q2 2024: BioLife Solutions Appoints New Chief Operating Officer to Lead Biopreservation Market Business Expansion BioLife Solutions appointed a new Chief Operating Officer to oversee the company’s biopreservation business, focusing on scaling operations and supporting global growth.
  • Q1 2024: Thermo Fisher Scientific Receives CE Mark for Biopreservation Market Media for Use in European Cell Therapy Manufacturing Thermo Fisher Scientific received CE Mark approval for its biopreservation media, enabling its use in cell therapy manufacturing across the European Union.
  • Q2 2024: BioCision Secures $20 Million Series C Funding to Accelerate Biopreservation Market Technology Development BioCision raised $20 million in Series C funding to support the development and commercialization of advanced biopreservation technologies for the life sciences sector.
  • Q1 2024: Panasonic Healthcare Partners with Leading Biobank to Supply Biopreservation Market Equipment Panasonic Healthcare entered into a partnership with a major biobank to supply ultra-low temperature freezers and related biopreservation equipment for long-term biological sample storage.
  • Q2 2024: BioLife Solutions Acquires Custom Biogenic Systems to Expand Biopreservation Market Product Offerings BioLife Solutions acquired Custom Biogenic Systems, a manufacturer of cryogenic storage equipment, to broaden its biopreservation solutions portfolio.
  • Q1 2024: Thermo Fisher Scientific Announces Contract to Supply Biopreservation Market Media to Major Cell Therapy Manufacturer Thermo Fisher Scientific signed a contract to supply its biopreservation media to a leading cell therapy manufacturer, supporting large-scale production of cell-based therapies.
  • Q2 2024: BioCision Launches New Modular Biopreservation Market Platform for Clinical Trial Sample Management BioCision launched a modular biopreservation platform designed to streamline the management and storage of clinical trial samples, enhancing sample integrity and traceability.

Future Outlook

Biopreservation Market Future Outlook

The Biopreservation Market is projected to grow at a 4.75% CAGR from 2025 to 2035, driven by advancements in preservation technologies and increasing demand for biopharmaceuticals.

New opportunities lie in:

  • <p>Development of advanced cryopreservation solutions for cell therapies. Integration of IoT for real-time monitoring of biopreservation conditions. Expansion of biopreservation services in emerging markets.</p>

By 2035, the Biopreservation Market is expected to achieve substantial growth, reflecting evolving industry needs.

Market Segmentation

Biopreservation Market End User Outlook

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Research Institutions
  • Hospitals
  • Clinics

Biopreservation Market Application Outlook

  • Cell and Tissue Culture
  • Gene and Drug Therapy
  • Clinical Applications
  • Regenerative Medicine

Biopreservation Market Product Type Outlook

  • Biopreservation Media
  • Freezers
  • Cryogenic Storage Systems
  • Accessories

Biopreservation Market Storage Type Outlook

  • Cryopreservation
  • Controlled Rate Freezing
  • Ultra-Low Temperature Storage

Report Scope

MARKET SIZE 2024 7.44(USD Billion)
MARKET SIZE 2025 7.793(USD Billion)
MARKET SIZE 2035 12.4(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.75% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Thermo Fisher Scientific (US), Merck KGaA (DE), Sartorius AG (DE), Danaher Corporation (US), BioLife Solutions (US), Lonza Group (CH), Fujifilm Holdings Corporation (JP), Becton, Dickinson and Company (US), Charles River Laboratories (US)
Segments Covered Application, Product Type, End User, Storage Type, Regional
Key Market Opportunities Advancements in microbial preservation techniques enhance product shelf life in the Biopreservation Market.
Key Market Dynamics Rising demand for biopreservation techniques driven by regulatory changes and technological advancements in food and pharmaceutical sectors.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Biopreservation Market as of 2024?

<p>The Biopreservation Market was valued at 7.44 USD Billion in 2024.</p>

What is the projected market size for the Biopreservation Market in 2035?

<p>The market is projected to reach 12.4 USD Billion by 2035.</p>

What is the expected CAGR for the Biopreservation Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Biopreservation Market during 2025 - 2035 is 4.75%.</p>

Which application segment is anticipated to grow the most in the Biopreservation Market?

<p>The Clinical Applications segment is expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.</p>

What are the key product types in the Biopreservation Market?

<p>Key product types include Biopreservation Media, Freezers, Cryogenic Storage Systems, and Accessories.</p>

How much is the Biopreservation Media segment projected to be worth by 2035?

<p>The Biopreservation Media segment is projected to reach 4.0 USD Billion by 2035.</p>

Which end-user segment is likely to see significant growth in the Biopreservation Market?

<p>Pharmaceutical Companies are expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.</p>

What storage type is projected to have the highest valuation in the Biopreservation Market by 2035?

<p>Ultra-Low Temperature Storage is projected to reach 5.07 USD Billion by 2035.</p>

Who are the leading companies in the Biopreservation Market?

<p>Key players include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, and Danaher Corporation.</p>

What is the growth outlook for the Cryopreservation segment in the Biopreservation Market?

<p>The Cryopreservation segment is expected to grow from 2.5 USD Billion in 2024 to 4.1 USD Billion by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Cell and Tissue Culture
    3. | | 4.1.2 Gene and Drug Therapy
    4. | | 4.1.3 Clinical Applications
    5. | | 4.1.4 Regenerative Medicine
    6. | 4.2 Healthcare, BY Product Type (USD Billion)
    7. | | 4.2.1 Biopreservation Media
    8. | | 4.2.2 Freezers
    9. | | 4.2.3 Cryogenic Storage Systems
    10. | | 4.2.4 Accessories
    11. | 4.3 Healthcare, BY End User (USD Billion)
    12. | | 4.3.1 Biotechnology Companies
    13. | | 4.3.2 Pharmaceutical Companies
    14. | | 4.3.3 Research Institutions
    15. | | 4.3.4 Hospitals
    16. | | 4.3.5 Clinics
    17. | 4.4 Healthcare, BY Storage Type (USD Billion)
    18. | | 4.4.1 Cryopreservation
    19. | | 4.4.2 Controlled Rate Freezing
    20. | | 4.4.3 Ultra-Low Temperature Storage
    21. | 4.5 Healthcare, BY Region (USD Billion)
    22. | | 4.5.1 North America
    23. | | | 4.5.1.1 US
    24. | | | 4.5.1.2 Canada
    25. | | 4.5.2 Europe
    26. | | | 4.5.2.1 Germany
    27. | | | 4.5.2.2 UK
    28. | | | 4.5.2.3 France
    29. | | | 4.5.2.4 Russia
    30. | | | 4.5.2.5 Italy
    31. | | | 4.5.2.6 Spain
    32. | | | 4.5.2.7 Rest of Europe
    33. | | 4.5.3 APAC
    34. | | | 4.5.3.1 China
    35. | | | 4.5.3.2 India
    36. | | | 4.5.3.3 Japan
    37. | | | 4.5.3.4 South Korea
    38. | | | 4.5.3.5 Malaysia
    39. | | | 4.5.3.6 Thailand
    40. | | | 4.5.3.7 Indonesia
    41. | | | 4.5.3.8 Rest of APAC
    42. | | 4.5.4 South America
    43. | | | 4.5.4.1 Brazil
    44. | | | 4.5.4.2 Mexico
    45. | | | 4.5.4.3 Argentina
    46. | | | 4.5.4.4 Rest of South America
    47. | | 4.5.5 MEA
    48. | | | 4.5.5.1 GCC Countries
    49. | | | 4.5.5.2 South Africa
    50. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Thermo Fisher Scientific (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Merck KGaA (DE)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Sartorius AG (DE)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Danaher Corporation (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 BioLife Solutions (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Lonza Group (CH)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Fujifilm Holdings Corporation (JP)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Becton, Dickinson and Company (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Charles River Laboratories (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USER
    6. | 6.6 US MARKET ANALYSIS BY STORAGE TYPE
    7. | 6.7 CANADA MARKET ANALYSIS BY APPLICATION
    8. | 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY END USER
    10. | 6.10 CANADA MARKET ANALYSIS BY STORAGE TYPE
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
    13. | 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    14. | 6.14 GERMANY MARKET ANALYSIS BY END USER
    15. | 6.15 GERMANY MARKET ANALYSIS BY STORAGE TYPE
    16. | 6.16 UK MARKET ANALYSIS BY APPLICATION
    17. | 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE
    18. | 6.18 UK MARKET ANALYSIS BY END USER
    19. | 6.19 UK MARKET ANALYSIS BY STORAGE TYPE
    20. | 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
    21. | 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    22. | 6.22 FRANCE MARKET ANALYSIS BY END USER
    23. | 6.23 FRANCE MARKET ANALYSIS BY STORAGE TYPE
    24. | 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
    25. | 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    26. | 6.26 RUSSIA MARKET ANALYSIS BY END USER
    27. | 6.27 RUSSIA MARKET ANALYSIS BY STORAGE TYPE
    28. | 6.28 ITALY MARKET ANALYSIS BY APPLICATION
    29. | 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    30. | 6.30 ITALY MARKET ANALYSIS BY END USER
    31. | 6.31 ITALY MARKET ANALYSIS BY STORAGE TYPE
    32. | 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
    33. | 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    34. | 6.34 SPAIN MARKET ANALYSIS BY END USER
    35. | 6.35 SPAIN MARKET ANALYSIS BY STORAGE TYPE
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY STORAGE TYPE
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY APPLICATION
    42. | 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    43. | 6.43 CHINA MARKET ANALYSIS BY END USER
    44. | 6.44 CHINA MARKET ANALYSIS BY STORAGE TYPE
    45. | 6.45 INDIA MARKET ANALYSIS BY APPLICATION
    46. | 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    47. | 6.47 INDIA MARKET ANALYSIS BY END USER
    48. | 6.48 INDIA MARKET ANALYSIS BY STORAGE TYPE
    49. | 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
    50. | 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    51. | 6.51 JAPAN MARKET ANALYSIS BY END USER
    52. | 6.52 JAPAN MARKET ANALYSIS BY STORAGE TYPE
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY STORAGE TYPE
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY END USER
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY STORAGE TYPE
    61. | 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
    62. | 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    63. | 6.63 THAILAND MARKET ANALYSIS BY END USER
    64. | 6.64 THAILAND MARKET ANALYSIS BY STORAGE TYPE
    65. | 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    67. | 6.67 INDONESIA MARKET ANALYSIS BY END USER
    68. | 6.68 INDONESIA MARKET ANALYSIS BY STORAGE TYPE
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY END USER
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY STORAGE TYPE
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
    75. | 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    76. | 6.76 BRAZIL MARKET ANALYSIS BY END USER
    77. | 6.77 BRAZIL MARKET ANALYSIS BY STORAGE TYPE
    78. | 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
    79. | 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    80. | 6.80 MEXICO MARKET ANALYSIS BY END USER
    81. | 6.81 MEXICO MARKET ANALYSIS BY STORAGE TYPE
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY END USER
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY STORAGE TYPE
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY STORAGE TYPE
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY STORAGE TYPE
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY STORAGE TYPE
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY END USER
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY STORAGE TYPE
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY STORAGE TYPE, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY STORAGE TYPE, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY STORAGE TYPE, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Cell and Tissue Culture
  • Gene and Drug Therapy
  • Clinical Applications
  • Regenerative Medicine

Healthcare By Product Type (USD Billion, 2025-2035)

  • Biopreservation Media
  • Freezers
  • Cryogenic Storage Systems
  • Accessories

Healthcare By End User (USD Billion, 2025-2035)

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Research Institutions
  • Hospitals
  • Clinics

Healthcare By Storage Type (USD Billion, 2025-2035)

  • Cryopreservation
  • Controlled Rate Freezing
  • Ultra-Low Temperature Storage
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓